Bicycle Therapeutics (BCYC) Depreciation and Depletion (2018 - 2024)

Bicycle Therapeutics has reported Depreciation and Depletion for 7 years, with the latest figure at $1.6 million in Q2 2024.

• For the quarter ending Q2 2024, Depreciation and Depletion changed 0.0% year-over-year to $1.6 million; the trailing twelve-month figure through Jun 2024 stood at $6.6 million (up 10.0% YoY), and the FY2023 full-year result was $6.5 million, up 75.68% from the prior year.
• Depreciation and Depletion for Q2 2024 stood at $1.6 million, down from $1.7 million in the prior quarter.
• The five-year high for Depreciation and Depletion was $1.7 million in Q3 2023, with the low at $300000.0 in Q1 2020.
• Historically, Depreciation and Depletion has averaged $900000.0 across 5 years, with a median of $500000.0 in 2020.
• Annual changes were most pronounced in 2020 — Depreciation and Depletion sank 50.0% — and 2022, when it jumped 333.33%.
• Bicycle Therapeutics' Depreciation and Depletion stood at $400000.0 in 2020, then changed by 0.0% to $400000.0 in 2021, then surged by 275.0% to $1.5 million in 2022, then advanced by 6.67% to $1.6 million in 2023, then changed by 0.0% to $1.6 million in 2024.
• The last three Depreciation and Depletion figures came in at $1.6 million (Q2 2024), $1.7 million (Q1 2024), and $1.6 million (Q4 2023), per Business Quant data.